-
Bio-Techne’s Ella Platform Secures CE-IVD Mark, Revolutionizing European Immunoassay Testing
NASDAQ: $TECH Bio-Techne Corporation, a leading global supplier of life science tools, reagents, and diagnostic products, has announced a major milestone: the Ella benchtop immunoassay platform has officially achieved CE-IVD marking and is now available for purchase throughout the European Union. This crucial certification opens the door for European clinical laboratories to adopt Ella’s industry-leading…